Additionally, if tau is proven to have a causal relationship with neurodegeneration and cognitive decline, the reduction of the tau signal in clinical trials may serve as a surrogate endpoint for halting or preventing the progression of cognitive decline. This evidence concerns the gene MAPT and Mental deterioration.